(Q37870031)

24 August 2017

1 reference

title

The "cryptic" mechanism of action of glucagon-like peptide-2. (English)

1 reference

24 August 2017

Katherine J Rowland

1

1 reference

PubMed ID

21527727

24 August 2017

Patricia L Brubaker

series ordinal

2

1 reference

24 August 2017

28 April 2011

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

24 August 2017

1 reference

24 August 2017

301

1 reference

24 August 2017

1

1 reference

24 August 2017

G1-8

1 reference

The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase.

24 August 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Role of phosphatidylinositol-3 kinase-gamma in the actions of glucagon-like peptide-2 on the murine small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

ErbB activity links the glucagon-like peptide-2 receptor to refeeding-induced adaptation in the murine small bowel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Identification of stem cells in small intestine and colon by marker gene Lgr5

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Modulation of specific intestinal epithelial progenitors by enteric neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Glucagon-like peptide-2 increases mesenteric blood flow in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

GLP-2 rapidly activates divergent intracellular signaling pathways involved in intestinal cell survival and proliferation in neonatal piglets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

A functional insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the epidermal growth factor receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Induction of intestinal epithelial proliferation by glucagon-like peptide 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Frontiers in glucagon-like peptide-2: multiple actions, multiple mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Glucagon-like peptide-2 activates beta-catenin signaling in the mouse intestinal crypt: role of insulin-like growth factor-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

21 January 2018

Glucagon-like Peptide-2.

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Early but not late administration of glucagon-like peptide-2 following ileo-cecal resection augments putative intestinal stem cell expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Strain-induced proliferation requires the phosphatidylinositol 3-kinase/AKT/glycogen synthase kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Endocrine tumour in kidney affecting small bowel structure, motility, and absorptive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Glucagon-like peptide-2 reduces intestinal permeability but does not modify the onset of type 1 diabetes in the nonobese diabetic mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

PTEN-deficient intestinal stem cells initiate intestinal polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Cross-talk between the ErbB/HER family and the type I insulin-like growth factor receptor signaling pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Glucagon-like peptide-2 does not modify the growth or survival of murine or human intestinal tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

The HeLa cell glucagon-like peptide-2 receptor is coupled to regulation of apoptosis and ERK1/2 activation through divergent signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Phosphoinositide 3-kinase signaling mediates beta-catenin activation in intestinal epithelial stem and progenitor cells in colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Mechanism of action of glucagon-like peptide-2 to increase IGF-I mRNA in intestinal subepithelial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Enteral nutrients potentiate the intestinotrophic action of glucagon-like peptide-2 in association with increased insulin-like growth factor-I responses in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

The role of insulin-like growth factors in small intestinal cell growth and development

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Molecular origins of cancer: Molecular basis of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Insulin-like growth factor I and glucagon-like peptide-2 responses to fasting followed by controlled or ad libitum refeeding in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Growth factors protect intestinal stem cells from radiation-induced apoptosis by suppressing PUMA through the PI3K/AKT/p53 axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Dietary regulation of intestinal gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Paneth cells constitute the niche for Lgr5 stem cells in intestinal crypts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Fasting induces a biphasic adaptive metabolic response in murine small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Glucagonoma syndrome demonstrating giant duodenal villi

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Tumor necrosis factor (TNF) alpha increases collagen accumulation and proliferation in intestinal myofibroblasts via TNF receptor 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Comparative effects of glucagon-like peptide-2 (GLP-2), growth hormone (GH), and keratinocyte growth factor (KGF) on markers of gut adaptation after massive small bowel resection in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Clinical relevance of systemic and local IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Glucagon-like peptide-2 receptor activation engages bad and glycogen synthase kinase-3 in a protein kinase A-dependent manner and prevents apoptosis following inhibition of phosphatidylinositol 3-kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

ErbB signaling is required for the proliferative actions of GLP-2 in the murine gut.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Enteroendocrine localization of GLP-2 receptor expression in humans and rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

The Intestinotrophic Peptide, GLP-2, Counteracts Intestinal Atrophy in Mice Induced by the Epidermal Growth Factor Receptor Inhibitor, Gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.00039.2011

21 January 2018

Identifiers

DOI

10.1152/AJPGI.00039.2011

1 reference

release_hq442yzqyzbh7o6oh6w5guzw3u

24 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hq442yzqyzbh7o6oh6w5guzw3u

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

21527727

1 reference

PubMed ID

21527727